Home › Funds › Sands Capital Alternatives, LLC › BBNX

Sands Capital Alternatives, LLC position in BBNX

BETA BIONICS INC · Health Care

Sands Capital Alternatives, LLC reported holding 3,997,898 shares of BBNX (BETA BIONICS INC) in its Q3 2026 13F filing — a position valued at US$75.9M, representing 11.23% of its reported portfolio and ranking #3 among its reported holdings. Sands Capital Alternatives, LLC has disclosed BBNX holdings in 7 of the last 7 reported quarters, going back to Q1 2025.

Latest position (Q3 2026)4.00M sh
Reported value held$75.88M
Portfolio Weight11.23%
First reportedQ1 2025
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Sands Capital Alternatives, LLC's BBNX position evolved

Sands Capital Alternatives, LLC first disclosed a stake in BBNX in Q1 2025 at 3,103,782 shares (US$38.0M). The position peaked in Q4 2025 at 3,570,113 shares, worth US$108.8M. Across 7 filings, Sands Capital Alternatives, LLC increased the stake 3 time(s), trimmed it 0 time(s) and left it unchanged 3 time(s). The most recent filing (Q3 2026) shows 3,997,898 shares valued at US$75.9M — an increase of 289,855 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q1 2025 3.10M $37.99M New
Q2 2025 3.57M $51.98M Add
Q3 2025 3.57M $70.94M Hold
Q4 2025 3.57M $108.78M Hold
Q1 2026 3.71M $37.15M Add
Q2 2026 3.71M $58.11M Hold
Q3 2026 4.00M $75.88M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About BBNX and 13F data

BBNX (BETA BIONICS INC) is a Health Care company. 56 other funds we track also report a position in BBNX — the largest reported positions include EVENTIDE ASSET MANAGEMENT, LLC (US$98.1M), Soleus Capital Management, L.P. (US$68.8M), Vestal Point Capital, LP (US$25.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding BBNX

All BBNX fund holders →

FAQ

How long has Sands Capital Alternatives, LLC held BBNX?

Sands Capital Alternatives, LLC has disclosed BBNX holdings in 7 of the last 7 reported quarters, going back to Q1 2025.

What is Sands Capital Alternatives, LLC's current position in BBNX?

As of Q3 2026, Sands Capital Alternatives, LLC holds 4.00M shares of BBNX (BETA BIONICS INC), valued at $75.88M, representing 11.23% of its reported portfolio and ranking #3.

Has Sands Capital Alternatives, LLC been buying or selling BBNX?

In the latest 13F filing (Q3 2026), Sands Capital Alternatives, LLC increased its position in BBNX. The position peaked in Q4 2025 at 3.57M shares.

Which other funds hold BBNX?

Other major institutional holders of BBNX include EVENTIDE ASSET MANAGEMENT, LLC, Soleus Capital Management, L.P., Vestal Point Capital, LP, among 56 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.